Cat. #161067
NCI-HPN-F44-Mam Cell Line
Cat. #: 161067
Availability: 8-10 weeks
Organism: Mouse
Tissue: Epithelial
Disease: Cancer
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Hesed Padilla-Nash
Institute: National Cancer Institute (NCI)
Primary Citation: Padilla-Nash et al. 2012. Genes Chrom Cancer. 51(4):353-374. PMID: 22161874.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: NCI-HPN-F44-Mam Cell Line
- Cancer: Breast cancer
- Cancers detailed: Breast cancer
- Research fields: Cancer
- Organism: Mouse
- Gender: Female
- Tissue: Epithelial
- Disease: Cancer
- Crispr: No
- Description: NCI-HPN-F44-Mam is produced from spontaneously transformed primary cell cultures without genetic, viral or chemical manipulation. This murine cell line is derived from normal epithelial cells in the mammary gland. Previous applications of this cell line include telomerase analysis by fluorescence in situ hybridisation (FISH). This in vitro model allows study of sequential genetic and genomic alterations in the natural process of oncogenesis.
- Application: Identification of cancer-specific genes & signalling pathways
- Biosafety level: 1
Applications
- Application: Identification of cancer-specific genes & signalling pathways
Handling
- Growth medium: DMEM/F12 media without phenol-red indicator (Invitrogen)
- Temperature: 37° C
- Atmosphere: 5% CO2
- Shipping conditions: Dry Ice
- Mycoplasma free: Yes
References
- Padilla-Nash et al. 2012. Genes Chrom Cancer. 51(4):353-374. PMID: 22161874.
